Philadelphia-based AI-enabled biotech company Vivodyne announced it closed a $38 million seed funding round led by Khosla Ventures. CS Ventures, Kairos Ventures, Bison Ventures and MBX Capital also participated in the round. WHAT IT DOES Vivodyne is a drug discovery company that uses clinically predictive AI to help identify therapeutic targets and predict a patient's response … [Read more...]